Navigation Links
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update
Date:3/25/2009

ADDISON, Texas, March 25 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that it has scheduled a conference call to discuss the fourth quarter and year ended 2008 financial results and provide a general business update on Tuesday, March 31, 2009 at 10:00 a.m. Eastern Time.

To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 9304#) five to ten minutes prior to the initiation of the teleconference. If you are unable to listen to the live broadcast, a replay of the call will be available starting on March 31, 2009 two hours following the end of the call until April 7, 2009 at 11:59 p.m. Eastern Time. For the U.S. replay, please dial (866) 415-9493 for international callers dial (585) 419-6446 (access code 9304#).

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex(TM) Aggregate technology and transmucosal delivery system. For more information about Altrazeal(TM), please visit http://www.altrazeal.com. For more information about ULURU Inc., please visit www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and other reports filed by us with the Securities and Exchange Commission.

    Contact: Company
    Renaat E. Van den H
'/>"/>
SOURCE  ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related medicine news :

1. ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board
2. ULURU Inc. Announces Senior Management Change
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2008 and to Provide a Business Update
4. ULURU Inc. Announces the Launch of the Altrazeal(TM) Website
5. ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
6. ULURU Inc. Announces Poster Presentations at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
7. ULURU Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2008
8. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
9. ULURU Inc. Reports First Quarter 2008 Financial Results
10. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
11. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... California (PRWEB) May 25, 2013 While ... honoring those who have died serving our Country, many ... with prolonged partying and recklessness. The DUI attorneys at ... Weekend DUI checklist to help keep this weekend’s party-goers ... Records System , there were more than 950 fatal ...
(Date:5/25/2013)... York (PRWEB) May 25, 2013 Life ... which are used to detect and create a new ... test reading and are also known as biotechnology reagents. ... bioscience, diagnosis and education. , This market is driven ... reagents in the field of therapeutics, growth in research ...
(Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...
(Date:5/25/2013)... Studies from Johns Hopkins University reveal a ... and their inability to get adequate sleep. These same ... naturally relieve many symptoms. , Johns Hopkins University ... was significantly associated with overall weight loss, especially belly ... November 6th, 2012, researchers monitored 77 participants who were ...
(Date:5/25/2013)... Pradaxa lawsuits filed on ... internal bleeding while using the blood thinner continue to mount ... District of Illinois, Bernstein Liebhard LLP reports. According to ... claims had been filed in the litigation as ... reported by the Court on May 15th. ( In Re: ...
Breaking Medicine News(10 mins):Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3
... of orphaned youth age 12 to 24 who head households ... report in the August issue of Archives of Pediatrics ... The combined effects of the 1994 genocide and the HIV ... in the worldan estimated 290,000 in 2005, according to background ...
... patient went home , , MONDAY, Sept. 1 (HealthDay News) ... in rehabilitation have less functional recovery, new research shows. ... published in the Sept. 1 issue of Sleep ... of recovery (e.g., mental status, hours of therapy received, ...
... Komen for the Cure(R), the,leader of the global ... G. Komen for the Cure Advocacy Alliance, are ... National Convention,about breast self awareness and to advocate ... uninsured and underinsured., (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ), ...
... WASHINGTON, Sept. 1 /PRNewswire-USNewswire/-- Service Employees,International Union (SEIU) ... RN, issued the following statement regarding the work,being ... country in anticipation of,the health impacts of Hurricane ... the Gulf Coast, leaders of the Nurse,Alliance of ...
... mandatory evacuations and the,approaching Hurricane Gustav, Pacer ... Louisiana medical facilities: South Cameron Memorial,Hospital (Cameron, ... LA). Effective immediately, both facilities will cease ... local and state officials.,Facility patients have been ...
... those unable to take ACE inhibitors , , SUNDAY, Aug. ... possible alternative to heart patients and diabetics who need ... cannot tolerate the standard treatment of ACE inhibitors. , ... on Sunday, Canadian researchers said they found that the ...
Cached Medicine News:Health News:Depression common among Rwandan youth who head households 2Health News:Daytime Sleeping Linked to Poor Recovery in Older Patients 2Health News:Komen Travels to Republican Convention to Raise Awareness of Breast Cancer Issues 2Health News:Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 2Health News:South Cameron Memorial Hospital and Calcasieu Oaks Psychiatric Hospital Discontinue Operations as Result of Impending Hurricane Gustav 2Health News:Newer Blood Pressure Drug Better for Some Heart Patients, Diabetics 2
(Date:5/24/2013)... In accordance with Rule 17.1 and Rule 2.9 ... United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") ... (NYSE: ELN). Background On 2 May ... for the entire of the issued and to be issued ... On 20 May 2013, Royalty Pharma announced ...
(Date:5/24/2013)... The potential of the pulmonary route as ... has been receiving undeniable attention with the recent advances ... crucial formulation considerations for orally inhaled products together with ... in the efficiency of pulmonary delivery, and great strides ... techniques and devices in recent years. With ...
(Date:5/23/2013)... , May 24, 2013 3SBio ... the "Company"), a leading China ... and marketing biopharmaceutical products, announced today that, at ... the Company,s shareholders voted in favor of the ... agreement and plan of merger dated February 8, ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... a clinico-molecular informatics company, today announced the commercialization ... lines that translate patient-specific molecular and genomic data, ... more effective drug choices for patients. ... drastically and clinical data becoming increasingly accessible, today,s ...
... /PR Newswire-Asia/ -- Global Pharm Holdings Group, Inc. ... growing vertically integrated pharmaceutical company engaged in the ... processing, and herbal cultivation and sales in China ... Shandong provinces, today announced the appointment of Mr. ...
Cached Medicine Technology:MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support 2MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support 3Global Pharm Holdings Group, Inc. Strengthens its Board by Adding a Non-Executive Director 2Global Pharm Holdings Group, Inc. Strengthens its Board by Adding a Non-Executive Director 3
The OneTouch Flexx Professional Blood Glucose Monitoring System with OneTouchPro Test Strips sets the standard for safety and convenience with unique off-meter sample application and a wide range of ...
... the market in New Technology, the Arrow ... whole new first and only IABP system ... a physiologically based timing algorithm, WAVE, to ... accuracy. Second generation Automaticity provides for ...
... NEXES Special Stains automated system ... to provide enhanced consistency of ... stains. Proprietary kinetic technology, including ... Mixing, assures high quality routine ...
... NexES IHC, the worlds first ... staining system introduced a whole ... while combining system modularity and ... laboratory productivity. The NexES Systems ...
Medicine Products: